BioMarin Pharmaceutical
BMRN
#1485
Rank
S$14.88 B
Marketcap
$77.64
Share price
0.60%
Change (1 day)
-36.91%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): S$0.72 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$2.85 Billion. , an increase over its 2023 earnings that were of S$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 S$0.71 B187.31%
2023 S$0.24 B26.07%
2022 S$0.19 B-298.51%
2021 -S$98.88 Million78.04%
2020 -S$55.54 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.19 Billion297.78%
2017 -S$47.08 Million-95.68%
2016 -S$1.1 Billion437.12%
2015 -S$0.21 Billion23.91%
2014 -S$0.17 Billion-29.25%
2013 -S$0.24 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$57.25 Million103.01%
2010 -S$28.2 Million-3903.54%
2009 S$0.74 M-98.31%
2008 S$43.85 M-189.7%
2007 -S$48.9 Million51.02%
2006 -S$32.38 Million-61.58%
2005 -S$84.27 Million-56.59%
2004 -S$0.2 Billion95.13%
2003 -S$99.47 Million12.09%
2002 -S$88.74 Million73.19%
2001 -S$51.24 Million18.32%
2000 -S$43.31 Million19.65%
1999 -S$36.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.67 Billion-193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.13 Billion-118.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.84 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.42 B 1,365.96%๐Ÿ‡ซ๐Ÿ‡ท France
-S$37.74 Million-105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.28 B-60.08%๐Ÿ‡บ๐Ÿ‡ธ USA